{"id":"https://openalex.org/W7225616652","doi":"https://doi.org/10.3390/ph19111780","title":"An Integrated NONMEM-Based Framework for Ticagrelor Exposure\u2013PRU Modeling and Patient-Level Outcome Prediction Assessment","display_name":"An Integrated NONMEM-Based Framework for Ticagrelor Exposure\u2013PRU Modeling and Patient-Level Outcome Prediction Assessment","publication_year":2026,"publication_date":"2026-11-09","ids":{"openalex":"https://openalex.org/W7225616652","doi":"https://doi.org/10.3390/ph19111780"},"language":"en","primary_location":{"id":"doi:10.3390/ph19111780","doi":"https://doi.org/10.3390/ph19111780","is_oa":true,"landing_page_url":"https://doi.org/10.3390/ph19111780","pdf_url":null,"source":{"id":"https://openalex.org/S16322639","display_name":"Pharmaceuticals","issn_l":"1424-8247","issn":["1424-8247"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceuticals","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.3390/ph19111780","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5048216405","display_name":"Songrui Du","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141942","display_name":"Peking University Third Hospital","ror":"https://ror.org/04wwqze12","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210141942"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Songrui Du","raw_affiliation_strings":["Center of Clinical Medical Research, Institute of Medical Innovation and Research, Peking University Third Hospital, Beijing 100191, China","Drug Clinical Trial Center, Department of Pharmacy, Peking University Third Hospital, Beijing 100191, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center of Clinical Medical Research, Institute of Medical Innovation and Research, Peking University Third Hospital, Beijing 100191, China","institution_ids":["https://openalex.org/I4210141942"]},{"raw_affiliation_string":"Drug Clinical Trial Center, Department of Pharmacy, Peking University Third Hospital, Beijing 100191, China","institution_ids":["https://openalex.org/I4210141942"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101601565","display_name":"Jingcheng Chen","orcid":"https://orcid.org/0000-0002-1199-9599","observed_orcids":["https://orcid.org/0000-0002-1199-9599"]},"institutions":[{"id":"https://openalex.org/I4210141942","display_name":"Peking University Third Hospital","ror":"https://ror.org/04wwqze12","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210141942"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jingcheng Chen","raw_affiliation_strings":["Center of Clinical Medical Research, Institute of Medical Innovation and Research, Peking University Third Hospital, Beijing 100191, China","Drug Clinical Trial Center, Department of Pharmacy, Peking University Third Hospital, Beijing 100191, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center of Clinical Medical Research, Institute of Medical Innovation and Research, Peking University Third Hospital, Beijing 100191, China","institution_ids":["https://openalex.org/I4210141942"]},{"raw_affiliation_string":"Drug Clinical Trial Center, Department of Pharmacy, Peking University Third Hospital, Beijing 100191, China","institution_ids":["https://openalex.org/I4210141942"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100369698","display_name":"Xiaodong Li","orcid":"https://orcid.org/0000-0002-2089-5046","observed_orcids":["https://orcid.org/0000-0002-2089-5046","https://orcid.org/0000-0002-0608-8192"]},"institutions":[{"id":"https://openalex.org/I20231570","display_name":"Peking University","ror":"https://ror.org/02v51f717","country_code":"CN","type":"education","lineage":["https://openalex.org/I20231570"]},{"id":"https://openalex.org/I4210141942","display_name":"Peking University Third Hospital","ror":"https://ror.org/04wwqze12","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210141942"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Dongyang Liu","raw_affiliation_strings":["Beijing Key Laboratory of Cardiovascular Receptors Research, Peking University Third Hospital, Beijing 100191, China","Center of Clinical Medical Research, Institute of Medical Innovation and Research, Peking University Third Hospital, Beijing 100191, China","Drug Clinical Trial Center, Department of Pharmacy, Peking University Third Hospital, Beijing 100191, China","State Key Laboratory of Vascular Homeostasis and Remodeling, NHC Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides, Peking University, Beijing 100191, China"],"raw_orcid":"https://orcid.org/0000-0002-0608-8192","affiliations":[{"raw_affiliation_string":"Beijing Key Laboratory of Cardiovascular Receptors Research, Peking University Third Hospital, Beijing 100191, China","institution_ids":["https://openalex.org/I4210141942"]},{"raw_affiliation_string":"Center of Clinical Medical Research, Institute of Medical Innovation and Research, Peking University Third Hospital, Beijing 100191, China","institution_ids":["https://openalex.org/I4210141942"]},{"raw_affiliation_string":"Drug Clinical Trial Center, Department of Pharmacy, Peking University Third Hospital, Beijing 100191, China","institution_ids":["https://openalex.org/I4210141942"]},{"raw_affiliation_string":"State Key Laboratory of Vascular Homeostasis and Remodeling, NHC Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides, Peking University, Beijing 100191, China","institution_ids":["https://openalex.org/I20231570"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101673628","display_name":"Cheng Cui","orcid":"https://orcid.org/0000-0001-6446-0127","observed_orcids":["https://orcid.org/0000-0001-6446-0127"]},"institutions":[{"id":"https://openalex.org/I4210141942","display_name":"Peking University Third Hospital","ror":"https://ror.org/04wwqze12","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210141942"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Cheng Cui","raw_affiliation_strings":["Center of Clinical Medical Research, Institute of Medical Innovation and Research, Peking University Third Hospital, Beijing 100191, China","Drug Clinical Trial Center, Department of Pharmacy, Peking University Third Hospital, Beijing 100191, China"],"raw_orcid":"https://orcid.org/0000-0001-6446-0127","affiliations":[{"raw_affiliation_string":"Center of Clinical Medical Research, Institute of Medical Innovation and Research, Peking University Third Hospital, Beijing 100191, China","institution_ids":["https://openalex.org/I4210141942"]},{"raw_affiliation_string":"Drug Clinical Trial Center, Department of Pharmacy, Peking University Third Hospital, Beijing 100191, China","institution_ids":["https://openalex.org/I4210141942"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5100369698","https://openalex.org/A5101673628"],"corresponding_institution_ids":["https://openalex.org/I20231570","https://openalex.org/I4210141942"],"apc_list":{"value":2900,"currency":"CHF","value_usd":3499},"apc_paid":{"value":2900,"currency":"CHF","value_usd":3499},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"19","issue":"11","first_page":"1780","last_page":"1780"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ticagrelor","display_name":"ticagrelor","score":1.0},{"id":"https://openalex.org/keywords/platelet-reactivity-units","display_name":"platelet reactivity units","score":0.9369999766349792},{"id":"https://openalex.org/keywords/population-pharmacokinetics","display_name":"population pharmacokinetics","score":0.8399999737739563},{"id":"https://openalex.org/keywords/pharmacokinetic-pharmacodynamic-modeling","display_name":"pharmacokinetic-pharmacodynamic modeling","score":0.8019999861717224},{"id":"https://openalex.org/keywords/indirect-response-model","display_name":"indirect response model","score":0.8600000143051147},{"id":"https://openalex.org/keywords/acute-coronary-syndrome","display_name":"acute coronary syndrome","score":0.8270000219345093},{"id":"https://openalex.org/keywords/bleeding-risk","display_name":"bleeding risk","score":0.8849999904632568},{"id":"https://openalex.org/keywords/ischemic-events","display_name":"ischemic events","score":0.906000018119812},{"id":"https://openalex.org/keywords/all-cause-mortality","display_name":"all-cause mortality","score":0.7649999856948853},{"id":"https://openalex.org/keywords/covariate-effects","display_name":"covariate effects","score":0.4970000088214874},{"id":"https://openalex.org/keywords/aspirin","display_name":"aspirin","score":0.4129999876022339},{"id":"https://openalex.org/keywords/fasting-effects","display_name":"fasting effects","score":0.652999997138977},{"id":"https://openalex.org/keywords/uk-biobank","display_name":"UK Biobank","score":0.6349999904632568}],"concepts":[{"id":"https://openalex.org/C2780890252","wikidata":"https://www.wikidata.org/wiki/Q420542","display_name":"Ticagrelor","level":4,"score":0.9340999722480774},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7856000065803528},{"id":"https://openalex.org/C2777698277","wikidata":"https://www.wikidata.org/wiki/Q266018","display_name":"Acute coronary syndrome","level":3,"score":0.6392999887466431},{"id":"https://openalex.org/C119043178","wikidata":"https://www.wikidata.org/wiki/Q320723","display_name":"Covariate","level":2,"score":0.6133999824523926},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5224999785423279},{"id":"https://openalex.org/C2776239304","wikidata":"https://www.wikidata.org/wiki/Q6954915","display_name":"NONMEM","level":3,"score":0.4456999897956848},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.4253999888896942},{"id":"https://openalex.org/C2909112448","wikidata":"https://www.wikidata.org/wiki/Q721432","display_name":"Platelet aggregation inhibitor","level":3,"score":0.4147999882698059},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.41359999775886536},{"id":"https://openalex.org/C2779384505","wikidata":"https://www.wikidata.org/wiki/Q17007513","display_name":"Concomitant","level":2,"score":0.37540000677108765},{"id":"https://openalex.org/C2778213512","wikidata":"https://www.wikidata.org/wiki/Q844935","display_name":"Coronary artery disease","level":2,"score":0.3621000051498413},{"id":"https://openalex.org/C116567970","wikidata":"https://www.wikidata.org/wiki/Q864217","display_name":"Biobank","level":2,"score":0.3522999882698059},{"id":"https://openalex.org/C49059817","wikidata":"https://www.wikidata.org/wiki/Q14916330","display_name":"P2Y12","level":4,"score":0.3257000148296356},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.32249999046325684},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.31150001287460327},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3012000024318695},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.2978000044822693},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.28839999437332153},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.28200000524520874},{"id":"https://openalex.org/C3017811039","wikidata":"https://www.wikidata.org/wiki/Q166019","display_name":"Major bleeding","level":3,"score":0.27630001306533813},{"id":"https://openalex.org/C2910001868","wikidata":"https://www.wikidata.org/wiki/Q458","display_name":"European union","level":2,"score":0.2754000127315521},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.27000001072883606},{"id":"https://openalex.org/C12174686","wikidata":"https://www.wikidata.org/wiki/Q1058438","display_name":"Risk assessment","level":2,"score":0.26930001378059387},{"id":"https://openalex.org/C2780272996","wikidata":"https://www.wikidata.org/wiki/Q1261151","display_name":"Therapeutic drug monitoring","level":3,"score":0.26899999380111694},{"id":"https://openalex.org/C2779974597","wikidata":"https://www.wikidata.org/wiki/Q28448986","display_name":"Clinical Practice","level":2,"score":0.2624000012874603},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.25850000977516174},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.25529998540878296},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.2551000118255615},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.25459998846054077}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.3390/ph19111780","doi":"https://doi.org/10.3390/ph19111780","is_oa":true,"landing_page_url":"https://doi.org/10.3390/ph19111780","pdf_url":null,"source":{"id":"https://openalex.org/S16322639","display_name":"Pharmaceuticals","issn_l":"1424-8247","issn":["1424-8247"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceuticals","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.3390/ph19111780","doi":"https://doi.org/10.3390/ph19111780","is_oa":true,"landing_page_url":"https://doi.org/10.3390/ph19111780","pdf_url":null,"source":{"id":"https://openalex.org/S16322639","display_name":"Pharmaceuticals","issn_l":"1424-8247","issn":["1424-8247"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceuticals","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4319063721","https://openalex.org/W4386704100","https://openalex.org/W7168172590","https://openalex.org/W2900070031","https://openalex.org/W2398625538","https://openalex.org/W4366983037","https://openalex.org/W3006613473","https://openalex.org/W2550728946","https://openalex.org/W2935153017","https://openalex.org/W7127655539"],"abstract_inverted_index":{"Background/Objectives:":[0],"Ticagrelor":[1],"reduces":[2],"ischemic":[3],"events":[4],"in":[5,14,45,77,102,237],"acute":[6],"coronary":[7],"syndrome":[8],"(ACS)":[9],"but":[10],"may":[11],"increase":[12],"bleeding":[13],"susceptible":[15],"patients.":[16],"We":[17,50,213],"used":[18,132],"a":[19,46,80,103,109,127,141,215,244],"population":[20,64],"PK":[21,65],"and":[22,29,35,66,73,87,122,149,156,182,189,207,222,254],"PK/PD":[23,68],"model":[24,139,163],"to":[25,99,169,225],"describe":[26],"ticagrelor":[27,56,219],"exposure":[28,96],"platelet":[30],"reactivity":[31],"unit":[32],"(PRU)":[33],"dynamics":[34,224],"assessed":[36],"whether":[37],"model-predicted":[38,123,194],"PRU":[39,74,92,124,171,195,223],"improved":[40],"prediction":[41,228],"of":[42],"subsequent":[43,100],"outcomes":[44,101],"patient-level":[47,226],"analysis.":[48,113,135],"Methods:":[49],"collated":[51],"published":[52],"evidence":[53],"from":[54,93],"39":[55],"clinical":[57,117,255,259],"studies":[58],"(172":[59],"group-level":[60],"datasets).":[61],"The":[62,137,161],"final":[63,138],"indirect-response":[67,162],"models":[69,115],"for":[70,133,205,246],"ticagrelor,":[71],"AR-C124910XX,":[72],"were":[75,125],"implemented":[76],"NONMEM":[78],"with":[79,116,144],"two-compartment":[81,142],"structure,":[82],"three":[83,145],"transit":[84,146],"absorption":[85,147],"compartments,":[86],"prespecified":[88,110],"covariate":[89],"relationships.":[90],"Model-predicted":[91],"recorded":[94,119],"prescription":[95],"was":[97,131,234],"linked":[98,164],"de-identified":[104],"UK":[105,175],"Biobank":[106,176],"cohort":[107],"using":[108,249],"90-day":[111,179],"landmark":[112,129],"Cox":[114],"variables,":[118],"medication":[120],"exposure,":[121,221],"compared;":[126],"30-day":[128],"analysis":[130],"sensitivity":[134],"Results:":[136],"retained":[140],"structure":[143],"compartments":[148],"quantified":[150],"age,":[151],"disease":[152],"status,":[153],"concomitant":[154],"aspirin,":[155],"fasting":[157],"effects":[158],"on":[159],"exposure.":[160],"combined":[165],"parent-metabolite":[166],"molar":[167],"concentration":[168],"continuous":[170],"dynamics.":[172],"In":[173],"731":[174],"participants,":[177],"the":[178,238,241],"ischemic,":[180],"bleeding,":[181],"all-cause":[183],"death":[184],"analyses":[185],"included":[186],"112,":[187],"48,":[188],"129":[190],"events,":[191],"respectively.":[192],"Adding":[193],"did":[196],"not":[197,235],"show":[198],"stable":[199],"incremental":[200,231],"discrimination;":[201],"all":[202],"paired-bootstrap":[203],"intervals":[204],"C-index":[206],"Brier-score":[208],"increments":[209],"crossed":[210],"zero.":[211],"Conclusions:":[212],"established":[214,236],"NONMEM-based":[216],"framework":[217,242],"linking":[218],"dosing,":[220],"outcome":[227,256],"assessment.":[229],"Although":[230],"predictive":[232],"benefit":[233],"current":[239],"cohort,":[240],"provides":[243],"basis":[245],"further":[247],"evaluation":[248],"paired":[250],"measured":[251],"PK,":[252],"PRU,":[253],"data":[257],"before":[258],"application.":[260]},"counts_by_year":[],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2026-11-10T00:00:00"}